首頁 > 市場調查報告書 > 製藥

循環系統

市場調查報告書

商品編碼

1547478

全球靜脈血栓栓塞治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Venous Thromboembolism Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球靜脈血栓栓塞治療市場的需求預計將從 2023 年的 127349 萬美元達到 2032 年的近 280958 萬美元，2024-2032 年研究期間複合年成長率為 9.19%。

靜脈血栓栓塞（VTE）是一種在上肢和下肢深層靜脈形成血栓，導致深部靜脈血栓（DVT）的疾病。當這些血塊到達肺部時，稱為肺栓塞（PE）。它會導致其中一根肺動脈阻塞。 VTE 是一種診斷不足但嚴重的疾病，甚至可能導致死亡和殘疾。 VTE 的可用治療方案是溶栓療法和抗凝血藥物（可作為血液稀釋劑）。靜脈血栓栓塞也可以用某些機械裝置來治療，例如加壓裝置、血栓切除系統和過濾器。

市場動態

全球靜脈血栓栓塞治療市場成長的主要驅動力是靜脈血栓栓塞發病率的增加和對現有治療方案的認知的提高。新型 VTE 治療設備的推出，增加患者的治療選擇數量將對 VTE 治療市場做出重大貢獻。此外，VTE治療的技術進步，例如肝素和低分子量相關抑制劑的開發，預計將為VTE市場帶來利潤豐厚的成長機會。然而，與新上市藥物和療法的批准和採用以及與 VTE 藥物相關的併發症相關的嚴格規則和法規可能會阻礙靜脈血栓栓塞治療市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球靜脈血栓栓塞治療市場的各個細分市場進行了包容性評估。靜脈血栓栓塞治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

靜脈血栓栓塞治療市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按設備

壓縮系統
血栓切除系統
下腔靜脈過濾器
絲襪
其他

按申請

深層靜脈栓塞
肺栓塞

按最終用途

醫院
導尿實驗室
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲靜脈血栓栓塞治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。靜脈血栓栓塞治療市場的主要參與者包括波士頓科學公司、AngioDynamics、Cardinal Health、Covidien、Daesung Maref、Cook Medical、Argon Medical Products。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：靜脈血栓栓塞治療公司的競爭格局

靜脈血栓栓塞治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Boston Scientific Corporation

公司概況
公司收入
產品
最新動態

AngioDynamics

公司概況
公司收入
產品
最新動態

Cardinal Health

公司概況
公司收入
產品
最新動態

Covidien

公司概況
公司收入
產品
最新動態

Daesung Maref

公司概況
公司收入
產品
最新動態

Cook Medical

公司概況
公司收入
產品
最新動態

Argon Medical Products

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215191

The global demand for Venous Thromboembolism Treatment Market is presumed to reach the market size of nearly USD 2809.58 Million by 2032 from USD 1273.49 Million in 2023 with a CAGR of 9.19% under the study period 2024-2032.

Venous thromboembolism (VTE) is a medical condition where blood clot is formed in the deep veins of the upper and lower extremities, resulting in deep vein thrombosis (DVT). When these blood clots reach the lungs, it is known as pulmonary embolism (PE). It leads to blockage of one of the pulmonary arteries. VTE is an underdiagnosed but serious condition, to the extent that it can even cause death and disability. The available treatment options for VTE are thrombolytic therapy and anticoagulant drugs, acting as blood thinners. Venous thromboembolism can also be treated with certain mechanical devices, such as, compression devices, thrombectomy systems and filters.

MARKET DYNAMICS

The key drivers behind global venous thromboembolism treatment market growth are increasing incidence of VTE and increasing awareness about the existing treatment options. Introduction of new VTE treatment devices, increasing the number of treatment choices for patients will contribute significantly towards VTE treatment market. Furthermore, technological advancements in VTE treatment, such as, development of heparins and associated inhibitors with low molecular weight are expected to bring lucrative growth opportunities for VTE market. However, strict rules and regulations related to approval and adoption of newly launched drugs and therapies and complications associated with VTE drugs may hamper the growth of venous thromboembolism treatment market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Venous Thromboembolism Treatment. The growth and trends of Venous Thromboembolism Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Venous Thromboembolism Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Device

Compression System
Thrombectomy Systems
IVC Filters
Stockings
Others

By Application

Deep Vein Thrombosis
Pulmonary Embolism

By End-use

Hospitals
Catheterization Laboratories
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Venous Thromboembolism Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Venous Thromboembolism Treatment market include Boston Scientific Corporation, AngioDynamics, Cardinal Health, Covidien, Daesung Maref, Cook Medical, Argon Medical Products. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. VENOUS THROMBOEMBOLISM TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Device
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY DEVICE

5.1. Overview By Device
5.2. Historical and Forecast Data Analysis By Device
5.3. Compression System Historic and Forecast Sales By Regions
5.4. Thrombectomy Systems Historic and Forecast Sales By Regions
5.5. IVCFilters Historic and Forecast Sales By Regions
5.6. Stockings Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Deep Vein Thrombosis Historic and Forecast Sales By Regions
6.4. Pulmonary Embolism Historic and Forecast Sales By Regions

7. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Catheterization Laboratories Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE VENOUS THROMBOEMBOLISM TREATMENT COMPANIES

9.1. Venous Thromboembolism Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF VENOUS THROMBOEMBOLISM TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Boston Scientific Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. AngioDynamics
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Cardinal Health
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Covidien
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Daesung Maref
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Cook Medical
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Argon Medical Products
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments